In addition, it has been shown that slow and passive drug release from drug-carrying particles reduces their effectiveness in cancer treatment [27].
passive polymer drug carriers have not demonstrated increased therapeutic efficacy due to lack of intercellular and localized, rapid drug delivery [28 - 30].